Hikma Subsidiary West-Ward Launches Dexrazoxane For Injection
LONDON (Alliance News) - Hikma Pharmaceuticals PLC on Friday said a US subsidiary has launched its version of Dexrazoxane for Injection, a generic equivalent for heart disease treatment is owned a Read More